Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Pharmacology|December 18, 2015
In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanideMaria D Donovan, Harriët Schellekens, Geraldine B Boylan, et al.
British Journal of Clinical Pharmacology|August 25, 2015
Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepilepticsMaria D Donovan, Geraldine B Boylan, Deirdre M Murray, et al.
The Journal of Pharmacy and Pharmacology|December 11, 2014
The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the ratMaria D Donovan, Fionn E O'Brien, Geraldine B Boylan, et al.
Advanced Drug Delivery Reviews|June 21, 2016
Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugsBrendan T Griffin, Jianfeng Guo, Elena Presas, et al.
Behavioural Brain Research|November 28, 2013
The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopramFionn E O'Brien, Richard M O'Connor, Gerard Clarke, et al.
Pageof 2